Cargando…
Dual VEGFA/BRAF targeting boosts PD‐1 blockade in melanoma through GM‐CSF‐mediated infiltration of M1 macrophages
The introduction of targeted therapies represented one of the most significant advances in the treatment of BRAFV600E melanoma. However, the onset of acquired resistance remains a challenge. Previously, we showed in mouse xenografts that vascular endothelial growth factor (VEGFA) removal enhanced th...
Autores principales: | Comunanza, Valentina, Gigliotti, Chiara, Lamba, Simona, Doronzo, Gabriella, Vallariello, Edoardo, Martin, Valentina, Isella, Claudio, Medico, Enzo, Bardelli, Alberto, Sangiolo, Dario, Di Nicolantonio, Federica, Bussolino, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399721/ https://www.ncbi.nlm.nih.gov/pubmed/37183363 http://dx.doi.org/10.1002/1878-0261.13450 |
Ejemplares similares
-
VEGF blockade enhances the antitumor effect of BRAF(V)
(600E) inhibition
por: Comunanza, Valentina, et al.
Publicado: (2016) -
Correction to: The role of redox system in metastasis formation
por: Cencioni, Chiara, et al.
Publicado: (2021) -
The role of redox system in metastasis formation
por: Cencioni, Chiara, et al.
Publicado: (2021) -
Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies
por: Comunanza, Valentina, et al.
Publicado: (2017) -
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway
por: Pergolizzi, Margherita, et al.
Publicado: (2022)